By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Edesa hands Kyorin Japan rights to its phase 3 respiratory antibody
    By
    msadmin
    November 9, 2026
    Cleerly trial shows AI plaque readings change how chest pain gets treated
    By
    msadmin
    November 9, 2026
    Northwell wins $3.4M to predict delirium before older patients slip
    By
    msadmin
    November 9, 2026
    NYU Langone AI flags trauma patients at risk of PTSD
    By
    msadmin
    November 9, 2026
    Primaa wins FDA breakthrough status for skin cancer slide AI
    By
    msadmin
    November 8, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Singapore clinics let an AI watch for referrals nobody ever sent
    By
    msadmin
    November 1, 2026
    An AI team of agents grades immunotherapy side effects
    By
    msadmin
    October 30, 2026
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

NYU Langone AI flags trauma patients at risk of PTSD

An ensemble of Llama, Mistral and DeepSeek scored emergency room narratives and caught every later PTSD case in a 145-patient test.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: November 9, 2026
Share
2 Min Read
SHARE

A team at NYU Langone Health has built an AI screener that estimates post-traumatic stress disorder risk by reading what patients say in the emergency department, aiming to catch the condition while care is still within reach.

Contents
Why emergency screening breaks downThree models, one risk scoreThe precision problem

The system, called PREVIA, published its results in Nature Communications on November 9. In a 145-patient study it reached 95.4 percent sensitivity, flagging every one of 30 patients who went on to develop PTSD a month later.

Why emergency screening breaks down

Only about 28 percent of US emergency departments routinely screen for PTSD, and just two-thirds of those use validated questionnaires, the study reports.

Clinicians have roughly 15 to 20 minutes per patient. A full mental health assessment rarely survives that squeeze, and many trauma patients have lost contact with the hospital by the time symptoms appear.

Three models, one risk score

Research coordinators asked patients at two New York City level-1 trauma centers to describe the event that brought them in, recording up to three minutes of video within 24 hours of arrival.

Llama and Mistral scored each transcript independently across eight domains covering symptoms, reactions and protective factors. DeepSeek reconciled the two readings, then a final assessor combined the summary with age, sex, trauma type and PTSD prevalence to yield a 0 to 100 risk score plus an explanation. The pipeline used zero-shot prompts with no fine-tuning on the study sample.

The precision problem

Overall discrimination landed at 78.5 percent AUROC, and precision was 46.8 percent, meaning most flagged patients would not develop PTSD. Sensitivity beat simpler configurations, and subthreshold cases reached 89.7 percent.

Senior author Katharina Schultebraucks, co-director of computational psychiatry at NYU Grossman School of Medicine, said the tool identifies at-risk patients and explains why without adding time to intake.

TAGGED:clinical screeningemergency medicinelarge language modelsmental health AINature CommunicationsNYU LangonePTSD
SOURCES:Nature CommunicationsNYU Langone HealthUnite.AI
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Sentara hands its discharge planners an AI chart reader

By
msadmin
October 21, 2026
News & Alerts

India puts 86 crore behind four AI designed drug candidates

By
msadmin
October 16, 2026
News & Alerts

Europe approves Vara’s AI to clear normal mammograms on its own

By
msadmin
September 5, 2026
News & Alerts

Nutshell can begin testing its molecular glue on US patients

By
msadmin
September 28, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal